EyePoint Pharmaceuticals
EYPT
#5901
Rank
โ‚น95.15 B
Marketcap
โ‚น1,149
Share price
3.24%
Change (1 day)
68.72%
Change (1 year)

Market capitalization of EyePoint Pharmaceuticals (EYPT)

Market cap: โ‚น95.15 Billion

As of February 2026 EyePoint Pharmaceuticals has a market cap of โ‚น95.15 Billion. This makes EyePoint Pharmaceuticals the world's 5901th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of EyePoint Pharmaceuticals from 2005 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น95.15 B-30%
2025โ‚น135.92 B222.44%
2024โ‚น42.15 B-55.13%
2023โ‚น93.96 B851.85%
2022โ‚น9.87 B-68.04%
2021โ‚น30.88 B324.17%
2020โ‚น7.28 B-39.8%
2019โ‚น12.09 B-4.04%
2018โ‚น12.60 B303.85%
2017โ‚น3.12 B-21.42%
2016โ‚น3.97 B-58.15%
2015โ‚น9.49 B23.87%
2014โ‚น7.66 B14.43%
2013โ‚น6.69 B333.8%
2012โ‚น1.54 B26.36%
2011โ‚น1.22 B-71.21%
2010โ‚น4.24 B38.28%
2009โ‚น3.06 B271.9%
2008โ‚น0.82 B3543.11%
2007โ‚น22.64 M-34.39%
2006โ‚น34.52 M-99.63%
2005โ‚น9.40 B

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of EyePoint Pharmaceuticals was reported to be:

โ‚น95.15 Billion
by Nasdaq info icon info icon
โ‚น95.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Nymox Pharmaceutical
NYMX
โ‚น1.64 B-98.27% Bahamas
NRC Health
NRC
โ‚น32.58 B-65.75%๐Ÿ‡บ๐Ÿ‡ธ USA